Fundraising Fox

LAVA Therapeutics

Founded 2016 · 7 employees on LinkedIn · 7 known investors

LAVA develops the Gammabody platform, which generates bispecific antibodies that activate gamma-delta T cells to treat cancer by directing immune cells to tumors and triggering anti-cancer immune responses.

Founders & leadership

LAVA Therapeutics was founded in 2016 by Ton Adang and Hans van der Vliet.

TATon Adang
Ton AdanginFounder
HVHans van der Vliet
Hans van der VlietinHead of Innovation
SHSteve Hurly
Steve HurlyChief Executive Officer
OPOxana Polyakova
Oxana PolyakovainChief Scientific Officer

Investors · 7

Also in the syndicate · 2

BB Pureos BioventuresVersant

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does LAVA Therapeutics do?
LAVA develops the Gammabody platform, which generates bispecific antibodies that activate gamma-delta T cells to treat cancer by directing immune cells to tumors and triggering anti-cancer immune responses.
Who founded LAVA Therapeutics?
LAVA Therapeutics was founded by Ton Adang, Hans van der Vliet in 2016.
Who are LAVA Therapeutics's investors?
LAVA Therapeutics's investors include MRL Ventures Fund, Sanofi Ventures, Ysios Capital, Gilde Healthcare, REDMILE.